Orebro Specialty Chemicals Private Limited - Company Profile

It is a business services private limited company based in Mumbai, Maharashtra, India, established in 2025.
2025 Mumbai, Maharashtra, India Active
Last Updated:
About Orebro Specialty Chemicals Private Limited

Orebro Specialty Chemicals Private Limited, a active private limited company, was established on 22 January 2025 in Mumbai, Maharashtra, India. it holds CIN: U47213MH2025PTC438627. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.10 M.

Formerly known as Pish Posh Private Limited. Its leadership includes Dharmin Hitendra Desai (Director), Rishi Ajoy Masand (Director). Its latest AGM occurred on 24 November 2025, with the balance sheet filed on 31 March 2025. It is based at 31St Floor, 3107, Kohinoor Square B, N C Kelkar Marg, Dadar West,, Mumbai, Maharashtra, 400028.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U47213MH2025PTC438627

  • Registration Number

    438627

  • Incorporation Date

    22 January 2025

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 1 Year 1 Month
  • Last Filing with ROC 31 Mar 2025
Company report

Orebro Specialty Chemicals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Orebro Specialty Chemicals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Orebro Specialty Chemicals Private Limited?
Current Directors
Name Designation Appointment Date Status
Dharmin Hitendra Desai Director 22 Jan 2025 Current
Rishi Ajoy Masand Director 22 Jan 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Orebro Specialty Chemicals.
Orebro Specialty Chemicals revenue growth over time
Orebro Specialty Chemicals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Orebro Specialty Chemicals?

Unlock access to Orebro Specialty Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Orebro Specialty Chemicals?

Unlock and access historical data on people associated with Orebro Specialty Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Orebro Specialty Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orebro Specialty Chemicals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Orebro Specialty Chemicals
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Orebro Specialty Chemicals Private Limited last Annual general meeting of members was held on 24 Nov 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Orebro Specialty Chemicals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

  • Director Appointment

    The activity Dharmin Hitendra Desai was appointed as a Director was appointed as a Director on 22 Jan 2025 & has been associated with this company since 1 year 1 month . was completed.

  • Director Appointment

    Progress on Rishi Ajoy Masand was appointed as a Director was appointed as a Director on 22 Jan 2025 & has been associated with this company since 1 year 1 month . was documented.

  • Company Incorporation

    Progress on Orebro Specialty Chemicals Private Limited was registered on 22 Jan 2025 with Roc Mumbai & aged 1 year 1 month as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Orebro Specialty Chemicals Private Limited?

The CIN of Orebro Specialty Chemicals Private Limited is U47213MH2025PTC438627.

Where is Orebro Specialty Chemicals Private Limited headquartered?

Orebro Specialty Chemicals Private Limited is headquartered at 31St Floor, 3107, Kohinoor Square B, N C Kelkar Marg, Dadar West,, Mumbai, Maharashtra, 400028.

When was Orebro Specialty Chemicals Private Limited incorporated?

Orebro Specialty Chemicals Private Limited was incorporated on 22 January 2025.

Who are the current directors of Orebro Specialty Chemicals Private Limited?

The current directors of Orebro Specialty Chemicals Private Limited are

Is Orebro Specialty Chemicals Private Limited a listed company?

Orebro Specialty Chemicals Private Limited is unlisted.

What is the capital structure of Orebro Specialty Chemicals Private Limited?

The authorized capital of Orebro Specialty Chemicals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available